S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
NCT01963325
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Cholangiocarcinoma
Interventions
DRUG:
S-1 plus Abraxane
Sponsor
Yuhong Li